SP2 and neoplasm: After detailed clinicopathological analysis, it was found that the expression of Sp2 was positively correlated with tumor size (P = .041), lymph node metastasis (P = .032), clinical stage (P = .011), but did not relate to the histological grade, gender and age of patients (Figure 1C; Table 1).